Thuy Nguyen
Primary Care · Jetmore, KSNPI 1720459662
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 269 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,013 and has fallen 99.0% since, to $20 in 2025. Among primary care clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 269 payments — averaging $16.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$982
- Amgen$447
- Amarin Pharma, Inc.$284
- Lilly USA, LLC$264
- Bayer$145
- plus $1K from 26 others
What the payments were for
- Food & beverage$4,418100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $1,018 |
| AbbVie | 78 | $982 |
| Amgen(2 entities) | 21 | $447 |
| Amarin Pharma, Inc. | 25 | $284 |
| Lilly USA, LLC | 22 | $264 |
| Bayer | 9 | $145 |
| Astellas Pharma US Inc | 8 | $136 |
| Esperion Therapeutics, Inc. | 7 | $134 |
| GSK | 2 | $129 |
| AstraZeneca | 8 | $128 |
| Pfizer | 7 | $113 |
| Organon | 2 | $92 |
| Johnson & Johnson | 5 | $91 |
| Jazz Pharmaceuticals Inc. | 4 | $60 |
| Merck | 3 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $41 |
| Neos Therapeutics, LP | 3 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Eisai Inc. | 1 | $20 |
| EMD Serono, Inc. | 1 | $18 |
| Corium, LLC | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Abbott | 1 | $13 |
| Upsher-smith Laboratories LLC | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Boehringer Ingelheim | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,418 in reported general payments places this provider in the 90th percentile of 56 primary care providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 21 | $133 |
| Atorvastatin Calcium | 12 | $84 |
| Lisinopril | 19 | $75 |
Paid to pharmacies, not to this prescriber.
Other primary care in Jetmore
- Michelle PragerTopeka$39K
- Kerry SanderStilwell$9K
- Kristina GroveOverland Park$9K
- Amy BakerLawrence$7K
- Debra LyneSalina$4K
- Phuong DuongWichita$3K
- Danielle CarmitchelOverland Park$2K
- Erika DickChanute$2K
- Jennifer ErkerGoddard$2K
- Mayra BrooksConcordia$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.